SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-17-000187
Filing Date
2017-02-14
Accepted
2017-02-14 17:36:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2017 dipexium13ga-021417.htm SC 13G/A 59176
  Complete submission text file 0001013594-17-000187.txt   60906
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 17610943
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019 212-554-2500
Tourbillon Capital Partners, L.P. (Filed by) CIK: 0001592476 (see all company filings)

IRS No.: 460724833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A